Assessment of anxiety and fear of COVID-19 in the prison population: Psychometric properties of the AMICO_Inmates scale.

Assessment of anxiety and fear of COVID-19 in the prison population: Psychometric properties of the AMICO_Inmates scale.

Publication date: Aug 29, 2025

The COVID-19 disease has entailed a public health challenge and an increased sense of uncertainty for the prison population, who have experienced restrictions on access to social contacts, communal areas, and information for a longer and more recent period than the general population, as well as increased levels of anxiety and fear associated with the COVID-19 disease. The objective of this study was the validation of the Anxiety and Fear of COVID-19 (AMICO) Assessment Scale to measure both anxiety and fear constructs in Spanish prison inmates. A descriptive psychometric validation study was carried out. A field study was conducted to perform univariate analyses, in addition to the exploratory and confirmatory factor analysis of the scale. The study sample consisted of 711 subjects over 18 years of age, inmates in Spanish prisons, 14. 1% of whom were women with a mean age of 40. 35 years (SD = 2. 62). The construct validity study reported 2 factors and 16 items, with a Cronbach alpha value of 0. 95, confirmed by McDonald Omega coefficient, with a value of 0. 951. The AMICO scale is a valid and reliable tool for assessing the level of anxiety and fear of COVID-19 in the Spanish adult prison population and shows high sensitivity.

Open Access PDF

Concepts Keywords
Amico_inmates Adult
Anxiety Anxiety
Mcdonald anxiety
Spanish COVID-19
Women COVID-19
criminals
Fear
fear
Female
Humans
instrument development
Male
mental health
Middle Aged
Prisoners
Prisons
prisons
Psychometrics
public health
Reproducibility of Results
SARS-CoV-2
Spain
Surveys and Questionnaires

Semantics

Type Source Name
disease MESH anxiety
disease MESH COVID-19
disease MESH uncertainty
disease MESH paranoia
disease MESH depression
disease MESH severe acute respiratory syndrome
pathway KEGG Influenza A
disease MESH morbidity
disease MESH infection
drug DRUGBANK Serine
disease MESH suicide
drug DRUGBANK Etoperidone
disease IDO cell
disease IDO history
disease MESH mental disorders
disease MESH mood disorders
disease MESH substance abuse
disease MESH psychosis
disease MESH compulsive behaviors
disease MESH violence
disease MESH recidivism
disease IDO replication
drug DRUGBANK Spinosad
disease IDO process
drug DRUGBANK Ademetionine
drug DRUGBANK Gold

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *